Progetti FP7 coordinati da "Fundacion centro nacional de investigaciones oncologicas carlos iii"
| # | ||||
|---|---|---|---|---|
| 1 | RAS:EFFECTORS RAS superfamily and the interactions with their effectors: functional specificity | 2007 | 30˙000.00 | 30˙000.00 |
| 2 | CHROMOREPAIR Genome Maintenance in the Context of Chromatin | 2008 | 948˙426.00 | 948˙426.00 |
| 3 | CANCER&AGEING COMMOM MECHANISMS UNDERLYING CANCER AND AGEING | 2009 | 2˙000˙000.00 | 2˙000˙000.00 |
| 4 | TEL STEM CELL FROM TELOMERE CHROMATIN TO STEM CELL BIOLOGY | 2009 | 2˙000˙000.00 | 2˙000˙000.00 |
| 5 | PA-CSC Molecular characterization and targeted elimination of metastatic pancreatic cancer stem cells | 2009 | 2˙335˙105.00 | 2˙335˙105.00 |
| 6 | AP-1-FUN AP-1 (Fos/Jun) Functions in Physiology and Disease | 2009 | 2˙500˙000.00 | 2˙500˙000.00 |
| 7 | HISTONEDDR ROLE OF HISTONE MODIFICATIONS IN DNA DAMAGE RESPONSE IN MAMMALS | 2009 | 237˙283.00 | 237˙283.00 |
| 8 | INFLAIDCAN The role of activation-induced cytidine deaminase in inflammation-induced carcinogenesis | 2010 | 161˙899.00 | 161˙899.00 |
| 9 | RAS AHEAD Ras Genes in Health and Disease | 2010 | 2˙496˙192.00 | 2˙496˙192.00 |
| 10 | DMONICKASEDESIGN Safer gene repair and targeting based on the monomeric meganuclease I-DmoI by design of homologous-recombination-inducing nickase activity | 2011 | 155˙417.00 | 155˙417.00 |
| 11 | CANCERALIA Development of novel diagnostic and therapeutic approaches to improve patient outcome in lung and pancreatic tumours | 2011 | 4˙155˙432.00 | 2˙996˙808.00 |
| 12 | SMARTBREAKER Rational designing of new meganucleases as molecular scissors for genomic tailoring | 2011 | 75˙000.00 | 75˙000.00 |
| 13 | PANCLON "Clonal analysis in pancreatic development, differentiation and carcinogenesis" | 2011 | 230˙980.00 | 230˙980.00 |
| 14 | MASTL CDC Role of the protein kinase Mastl in Cell Division and Cancer | 2012 | 226˙548.00 | 226˙548.00 |
| 15 | PERSMEDOMICS Bioinformatics and Integrative Genomics for a Novel Personalized Cancer Therapy | 2013 | 100˙000.00 | 100˙000.00 |
| 16 | RSHEALTH Investigating the causes and consequences of replication stress in mammalian health | 2014 | 1˙997˙819.00 | 1˙997˙819.00 |
| 17 | GLIDD DNA Damage Response (DDR) signaling in tumor formation and therapeutic resistance of gliomas | 2014 | 100˙000.00 | 100˙000.00 |
Altri progetti
L'Ente fundacion centro nacional de investigaciones oncologicas carlos iii partecipato anche in questi progetti.
- KIBINDING (2013, participant)
- ADDRESS (2012, participant)
- RD-CONNECT (2012, participant)
- RISK - IR (2012, participant)
- CAM-PAC (2013, participant)
- TRANSBIOBC (2013, participant)
- RSHEALTH (2014, hostInstitution)
- RSHEALTH (2014, hostInstitution)
- ELIXIR (2007, participant)
- SUPERCOMPETITORS (2008, beneficiary)
- BCLYM (2008, beneficiary)
- TARPOL (2008, participant)
- CANCERDIP (2008, participant)
- MARK-AGE (2008, participant)
- TELOMARKER (2008, participant)
- DECANBIO (2008, participant)
- GENICA (2008, participant)
- UROMOL (2008, participant)
- CHROMOREPAIR (2008, hostInstitution)
- CHROMOREPAIR (2008, hostInstitution)
- INFLA-CARE (2009, participant)
- CANCER&AGEING (2009, hostInstitution)
- CANCER&AGEING (2009, hostInstitution)
- TEL STEM CELL (2009, hostInstitution)
- TEL STEM CELL (2009, hostInstitution)
- PA-CSC (2009, hostInstitution)
- PA-CSC (2009, hostInstitution)
- COGS (2009, participant)
- EUROCANCERCOMS (2009, participant)
- AP-1-FUN (2009, hostInstitution)
- AP-1-FUN (2009, hostInstitution)
- NUCLEOSOME4D (2009, participant)
- MICROME (2009, participant)
- RAS AHEAD (2010, hostInstitution)
- RAS AHEAD (2010, hostInstitution)
- MITOSYS (2010, participant)
- ASSET (2010, participant)
- ENS@T-CANCER (2011, participant)
- EUROBATS (2011, participant)
- LUNGTARGET (2011, participant)
- EPC-TM-NET (2011, participant)
- EUROCANPLATFORM (2011, participant)
- MULTIFUN (2011, participant)
- BLUEPRINT (2011, participant)